CD4 and psoriasis: BA was previously found to be able to ameliorate psoriasis-like murine skin inflammation by decreasing the number of γδ T cells and IL-17A-expressing CD4+ in psoriatic mice, and inhibiting the proliferation of T cell and IL-17A production by CD4+ T-Cells in vitro [20].